Hypertension Trial, Recruiting NCT07439939 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07439939
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years old or older and covered by a social security (health insurance) scheme, or be a dependent of someone who is
  • You must be a patient being treated for cirrhosis (liver scarring) at Paul Brousse Hospital and be scheduled to have a procedure called a TIPS (a small device placed inside the liver to help reduce blood pressure in the liver's blood vessels)

Who may not be able to join:

  • You do not want to take part in the study
  • You have a medical reason why the TIPS procedure would not be safe for you (confirm with trial site)
  • You have a known blood clotting or bleeding disorder that is not caused by your cirrhosis
  • You are taking medication that affects how your blood clots, and it has not been stopped ahead of the procedure
  • You are currently taking steroid tablets or injections that affect your whole body (such as prednisone or dexamethasone)
  • You are under legal guardianship or another form of legal protection
  • You are not covered by a social security (health insurance) scheme

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 March 2026
Est. completion
9 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Area Under the Curve (AUC) of primary hemostasis assessed by T-TAS®01 at 10 minutes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov